RS Breakdown — momZ +0.41 · low 9w×1.00 · vs industry
About NextCure Inc
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targetin… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: May 9, 2019
Headquarters: 9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Founder-Led: Yes — Michael Richman (President & CEO)
Key Metrics
Current Price
$5.83
Market Cap
$28.6M
Float
2.9M
Shares Outstanding
4.6M
Price/Sales (TTM)
9.52
vs. Analyst Target
+285.9% to analyst PT
Dividend Rate
None
Analyst Target Price
$22.50 (2 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$22.4M
-$33.2M
$22.4M
-$37.8M
2021
N/A
-$69.4M
-$4.3M
-$65.1M
2022
N/A
-$69.4M
-$4.5M
-$71.8M
2023
N/A
-$62.7M
-$3.7M
-$59.0M
2024
N/A
-$55.7M
-$2.9M
-$54.3M
2025
N/A
-$55.8M
-$2.2M
-$53.7M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
N/A
-$8.6M
Dec 2025
N/A
-$9.4M
Mar 2026
N/A
-$9.8M
Jun 2026
N/A
-$14.9M
Ownership & Float
Insider Ownership
8.6%
Institutional Ownership
37.0%
Short Float
4.8%
% of All Funds Holding
0.34%
Number of Funds Holding
30
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$4.60
Near-term / short-term trend
Weekly
40-Week SMA
$8.97
Medium-term trend
Weekly
80-Week SMA
$7.77
Cyclical trend (business cycle)
Weekly
200-Week SMA
$13.51
Secular trend (multi-year)
Monthly
10-Month SMA
$8.95
Near-term monthly trend
Monthly
20-Month SMA
$7.99
Medium-term monthly trend
Monthly
40-Month SMA
$12.57
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.70
support
9.15x
0 months ago
$6.90
resistance
3.10x
1 months ago
Historical Earnings Reactions (30 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.20%
0.00%
43.33%
7.38%
-5.72%
1 Day
-0.19%
-0.34%
43.33%
13.10%
-21.12%
1 Week
0.86%
-0.73%
40.00%
46.87%
-29.48%
2 Weeks
-1.55%
-1.45%
46.67%
28.59%
-40.64%
1 Month
-5.54%
-2.71%
41.38%
52.85%
-78.09%
Next earnings: October 25, 2026 (59 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-2.7%
57.1%
7
Feb
4.6%
28.6%
7
Mar
-7.7%
14.3%
7
Apr
-14.3%
14.3%
7
May
-0.9%
42.9%
7
Jun
-12.6%
50.0%
8
Jul
14.0%
37.5%
8
Aug
5.9%
57.1%
7
Sep
-8.5%
14.3%
7
Oct
13.6%
42.9%
7
Nov
6.2%
57.1%
7
Dec
-2.2%
42.9%
7
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.65%
46.5%
344
Tuesday
1.07%
47.5%
379
Wednesday
-0.22%
45.1%
375
Thursday
0.38%
46.6%
367
Friday
-0.27%
42.0%
367
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 37.0%
Insider Transactions — Smart Summary
Total insider ownership: 8.6%
Founder-led management: Michael Richman (President & CEO)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for NextCure Inc
(NXTC) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.